OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - OREXIGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 27 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$0–33,3330.0%0.00%–
Q4 2017$0–33,3330.0%0.00%–
Q3 2017$0–33,3330.0%0.00%–
Q2 2017$0–33,3330.0%0.00%–
Q1 2017$0–33,333–0.00%–
 Download
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 28,420$1,0000.00%
AdvisorNet Financial, Inc 1,590$00.00%
SIMPLEX TRADING, LLC 5,500$00.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 100$00.00%
View complete list of OREXIGEN THERAPEUTICS INC shareholders